Results 31 to 40 of about 284,282 (314)

Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults — Nine States, January–September 2021

open access: yesMMWR. Morbidity and mortality weekly report, 2021
Immunocompromised persons, defined as those with suppressed humoral or cellular immunity resulting from health conditions or medications, account for approximately 3% of the U.S. adult population (1).
P. Embí   +53 more
semanticscholar   +1 more source

Novel Polyomaviruses in Mammals from Multiple Orders and Reassessment of Polyomavirus Evolution and Taxonomy

open access: yesViruses, 2019
As the phylogenetic organization of mammalian polyomaviruses is complex and currently incompletely resolved, we aimed at a deeper insight into their evolution by identifying polyomaviruses in host orders and families that have either rarely or not been ...
Bernhard Ehlers   +24 more
doaj   +1 more source

Pneumococcal Vaccination in Immunocompromised Hosts: An Update

open access: yesVaccines, 2021
Infections with the pathogen, Streptococcus pneumoniae, are a common cause of morbidity and mortality worldwide. It particularly affects those at the extremes of age and immunocompromised individuals.
Claire Froneman   +2 more
doaj   +1 more source

Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review

open access: yesClinical Microbiology and Infection, 2021
Background Available data show that COVID-19 vaccines may be less effective in immunocompromised populations, who are at increased risk of severe COVID-19.
S. Galmiche   +6 more
semanticscholar   +1 more source

Extracorporeal membrane oxygenation in immunocompromised patients with acute respiratory failure: A retrospective cohort study

open access: yesThe Clinical Respiratory Journal, 2023
Background The clinical indications of extracorporeal membrane oxygenation (ECMO) in immunosuppressed patients are not clear. This study aimed to analyse the effectiveness of ECMO and to identify the risk factors for the mortality of ECMO in ...
Ye Tian   +11 more
doaj   +1 more source

Lomentospora prolificans Disseminated Infections: A Systematic Review of Reported Cases

open access: yesPathogens, 2022
Background: Lomentospora prolificans, a rare, highly virulent filamentous fungus with high rates of intrinsic resistance to antifungals, has been associated with different types of infections in immunocompromised as well as immunocompetent individuals ...
Afroditi Konsoula   +4 more
doaj   +1 more source

Micafungin Compared with Caspofungin for the Treatment of Febrile Episodes in Neutropenic Patients with Hematological Malignancies: A Retrospective Study

open access: yesCanadian Journal of Infectious Diseases and Medical Microbiology, 2014
BACKGROUND: Invasive fungal infections are associated with morbidity and mortality in neutropenia secondary to hematological malignancies. Empirical antifungal agents are used to reduce their consequences.
Sarah Shalhoub   +4 more
doaj   +1 more source

Chronic Candida dubliniensis meningitis in a lung transplant recipient

open access: yesMedical Mycology Case Reports, 2019
Candida spp. are common colonizers of the oral mucosa and respiratory tract in lung transplant recipients. Although thought to be non-pathogenic in most cases, donor derived infections related to Candida spp. have been described. Among the manifestations
Sabina Herrera   +8 more
doaj   +1 more source

Vaccination Coverage among Immunocompromised Patients in a Large Health Maintenance Organization: Findings from a Novel Computerized Registry

open access: yesVaccines, 2022
Immune-compromised patients (IPs) are at high risk for infections, some of which are preventable by vaccines. Specific vaccines are recommended for IP; however, the vaccination rate is suboptimal.
Shirley Shapiro Ben David   +3 more
doaj   +1 more source

Pre-exposure prophylaxis with tixagevimab and cilgavimab (Evusheld) for COVID-19 among 1112 severely immunocompromised patients

open access: yesClinical Microbiology and Infection, 2022
Objective Immunocompromised patients have an increased risk of a severe form of COVID-19. The clinical efficacy of the tixagevimab/cilgavimab monoclonal antibody combination as pre-exposure prophylaxis against BA.1 and BA.2 SARS-CoV-2 Omicron sublineages
Yann Nguyen   +27 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy